Harbour Investments, Inc. Adamis Pharmaceuticals Corp Transaction History

Harbour Investments, Inc.

  • $3.14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.34 - $0.57 $4,372 - $7,330
12,860 New
12,860 $6,000
Q4 2021

Feb 16, 2022
SELL
$0.57 - $1.23 $1,140 - $2,460
-2,000 Closed
0 $0
Q1 2021

Aug 17, 2021
BUY
$0.54 - $1.79 $1,080 - $3,580
2,000 New
2,000 $2,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email